Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intratumoral Injection of IP-001 Following Standard-of-care Complete Hepatic Tumor Ablation in Patients With Liver-only Metastatic Colorectal Cancer

NCT07321847 is registered in ClinicalTrials.gov with Immunophotonics, Inc. as lead sponsor.

NCT NCT07321847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intratumoral Injection of IP-001 Following Standard-of-care Complete Hepatic Tumor Ablation in Patients With Liver-only Metastatic Colorectal Cancer
Lead sponsor
Immunophotonics, Inc.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
December 31, 2033
Enrollment
717 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer liver metastases, colorectal cancer (crc), colorectal liver metastasis (crlm), rectal cancer, rectal cancer with liver metastases